SC
NUVB icon

Sapient Capital’s Nuvation Bio NUVB Stock Holding History

Sapient Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$176K Hold
31,450
– – ﹤0.01% 383
2026
Q2 		$179K Hold
31,450
– – ﹤0.01% 387
2026
Q1 		$135K Hold
31,450
– – ﹤0.01% 435
2025
Q4 		$281K Hold
31,450
– – ﹤0.01% 346
2025
Q3 		$101K Buy
+31,450
New +$85.7K ﹤0.01% 381

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $313M AUM 15.55% 1-Year Est. Return
EWA
Emergent Wealth Advisors Williamsville, New York $191M AUM 17.3% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Sapient Capital's NUVB Position: Q3 2026 in Review

Sapient Capital held its Nuvation Bio (NUVB) position steady in Q3 2026 at 31,450 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #383.

Sapient Capital first reported a position in NUVB in Q3 2025 and has held it in 5 quarters since. The position peaked at $281K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Sapient Capital held 31,450 shares of Nuvation Bio worth $176K as of Q3 2026.
  • Sapient Capital left its Nuvation Bio share count unchanged in Q3 2026.
  • Nuvation Bio made up ﹤0.01% of Sapient Capital's portfolio in Q3 2026, its #383 holding.
  • Sapient Capital first reported a position in Nuvation Bio in Q3 2025 and has held it in 5 quarters since.
  • Sapient Capital's Nuvation Bio position peaked at $281K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.